How is the Micral urine test performed and interpreted for screening microalbuminuria in adult patients with diabetes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Micral Test Urine

The Micral test is a semiquantitative immunologic dipstick that can be used for rapid screening of microalbuminuria in diabetic patients when quantitative urine albumin-to-creatinine ratio (UACR) testing is not immediately available, but positive results must be confirmed with laboratory-based UACR measurement 1.

How to Perform the Test

Sample Collection

  • Use a first morning void urine sample for optimal accuracy 1
  • If first morning void is difficult to obtain, collect all samples at the same time of day 1
  • Patient should be well hydrated, have not eaten within 2 hours, and have not exercised 1
  • Test the sample immediately or within a short time frame

Test Procedure

  • Dip the Micral test strip into the urine sample
  • Wait 1 minute for color development (if massive leucocyturia or erythrocyturia is present, wait an additional 1-2 minutes) 2
  • Read the color scale on the strip, which provides semiquantitative results in mg/L
  • The test detects albumin concentrations from 0 to 100 mg/L using an immunologic reaction 2

Interpretation

Cutoff Values

  • Microalbuminuria range: 20-200 mg/L on spot urine 3, 4
  • The optimal cutoff for screening is approximately 20-30 mg/L 5, 6
  • Results ≥20 mg/L should be considered positive for screening purposes

Performance Characteristics in Diabetic Patients

The test demonstrates good but not perfect accuracy 5, 6, 7:

  • Sensitivity: 83-96% (most studies show ~90-95%)
  • Specificity: 80-96%
  • Positive predictive value: 69-95%
  • Negative predictive value: 88-99%

Critical Limitations and Pitfalls

Must Confirm Positive Results

Semiquantitative or qualitative screening tests should be positive in >85% of individuals with moderately increased albuminuria, but positive results require confirmation with quantitative laboratory UACR 1. The guideline explicitly states that dipstick screening is "susceptible to false-negative and false-positive determinations" and "will need to be confirmed by UACR values in an accredited laboratory" 8.

Factors Affecting Accuracy

  • Urine concentration: The test is affected by hydration status 8, 6
  • Temperature: Samples <10°C produce falsely low readings 2
  • Medications: Oxytetracycline causes falsely elevated readings 2
  • Urine sediment: Massive leucocyturia or erythrocyturia may interfere with the chromatographic process 2
  • Specific gravity: Concomitant measurement of specific gravity helps identify false positives and negatives 6

Clinical Algorithm

  1. Screen annually starting at diabetes diagnosis for type 2 diabetes 1
  2. If Micral test is negative (<20 mg/L): Repeat annually
  3. If Micral test is positive (≥20 mg/L):
    • Confirm with laboratory UACR measurement on a first morning void specimen 8, 1
    • Do not make treatment decisions based on Micral test alone 7
  4. If UACR confirms microalbuminuria (30-300 mg/g creatinine):
    • Repeat every 6 months if eGFR <60 mL/min/1.73 m² 1
    • Initiate appropriate treatment (ACEI/ARB, blood pressure control, glycemic control)

When to Use Quantitative UACR Instead

It is better to simply collect a spot urine sample for UACR rather than using semiquantitative dipsticks 8. The Micral test should only be used "when quantitative tests are not available" 1. In settings with laboratory access, proceed directly to UACR measurement rather than screening with dipsticks, as this avoids the need for confirmatory testing and provides more accurate quantification for treatment decisions.

Related Questions

In a 58-year-old man with diabetes mellitus on metformin (Glucophage) and atorvastatin, normal blood pressure, well-controlled HbA1c, and a first-time urine albumin-to-creatinine ratio indicating microalbuminuria, what is the most appropriate next step?
What is the appropriate management for a prediabetic patient with microalbuminuria (urine albumin 141 mg)?
In a patient with a normal estimated glomerular filtration rate of 109 mL/min/1.73 m² and confirmed microalbuminuria of 43.6 mg/g, what management steps should be taken?
How should I interpret a serum creatinine of 270 µmol/L with urine albumin <12 mg/L and what management steps are recommended?
What is the appropriate management for a 55-year-old man with hypertension and microalbuminuria (elevated urine albumin-to-creatinine ratio)?
Is Entresto (sacubitril/valsartan) safe in patients with systolic blood pressure below 100 mmHg?
Why are fluoroquinolone ophthalmic drops less hazardous than oral fluoroquinolone tablets?
Can long-term twice-daily proton-pump inhibitor (PPI) therapy affect serum ferritin levels?
What is the appropriate management for a 78-year-old female with chronic obstructive pulmonary disease exacerbation who is receiving systemic corticosteroids and azithromycin, has back pain that worsens with coughing, and experiences shortness of breath with activity?
How should I give 8 mg dexamethasone diluted in 100 mL of normal saline intravenously over 30 minutes?
Should a gastric mucosal biopsy be performed for Helicobacter pylori culture and antimicrobial susceptibility testing?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.